Medpace Holdings Inc (MEDP)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $18.29B
Last updated: Nov 17, 2026 at 11:06 AM ET
Medpace Holdings Inc (MEDP) P/E Ratio & Valuation History
Medpace Holdings (MEDP) trades at 35.9x trailing earnings and 6.4x sales. Its P/E of 35.9x is above its 5-year median of 30.1x. Its forward P/E is 33.1x. The median P/E across 11 similar companies is 26.8x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 8.5% higher over the next year. Its free cash flow yield is 3.7%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 35.9x |
| Forward P/E | 33.1x |
| Price to sales | 6.4x |
| Price to book | 31.0x |
| EV/EBITDA | 27.4x |
| Price to FCF | 27.1x |
| EV/FCF | 26.1x |
| PEG | 3.4 |
| FCF yield | 3.7% |
Historical Medians
Against its 10-year medians, its P/E is 24.2% above 28.9x, its P/S is 42.2% above 4.5x and its P/B is 307.9% above 7.6x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 35.9x | 30.1x | 28.9x |
| P/S | 6.4x | 5.0x | 4.5x |
| P/B | 31.0x | 17.8x | 7.6x |
Valuation History
Over the 9 of the 10 year ends shown that have a P/E, its P/E ranged from 20.4x in 2018 to 44.3x in 2021.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $561.65 | 36.7x | 6.4x | 35.4x |
| 2024 | $332.23 | 26.2x | 4.9x | 12.9x |
| 2023 | $306.53 | 34.3x | 5.0x | 17.5x |
| 2022 | $212.41 | 28.8x | 4.7x | 17.8x |
| 2021 | $217.64 | 44.3x | 6.9x | 8.6x |
| 2020 | $139.20 | 35.1x | 5.4x | 6.5x |
| 2019 | $84.06 | 27.9x | 3.6x | 4.4x |
| 2018 | $52.93 | 20.4x | 2.7x | 3.3x |
| 2017 | $36.26 | 24.0x | 3.3x | 2.7x |
| 2016 | $36.07 | N/A | 3.4x | 2.4x |
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About MEDP
What is MEDP's forward P/E ratio?
Medpace Holdings has a forward P/E ratio of 33.1x.
Is MEDP stock overvalued?
GNG's valuation label for MEDP is Overvalued. Its P/E of 35.9x compares with a median of 26.8x across 11 similar companies.
What is MEDP's price to sales ratio?
Medpace Holdings has a price to sales ratio of 6.4x.
What is Medpace Holdings's average P/E ratio over 5 years?
Medpace Holdings's median P/E over the last 5 years is 30.1x, from 60 month-end values through Oct 2026.
What is MEDP's PEG ratio?
Medpace Holdings has a PEG ratio of 3.4.
MEDP pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors